Department of Epidemiology, School of Public Health, Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.
Department of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Cancer Control. 2024 Jan-Dec;31:10732748241266508. doi: 10.1177/10732748241266508.
Acute lymphocytic leukemia is a cancer affecting the blood and bone marrow and is the most frequently diagnosed cancer among children. In Ethiopia, it represents the predominant form of childhood leukemia, comprising approximately 80% of cases and serving as a leading cause of childhood cancer-related deaths. Therefore, the objective of this study is to examine the survival status and factors that may predict mortality in children admitted with acute lymphocytic leukemia at cancer treatment hospitals in Addis Ababa, Ethiopia.
A retrospective follow-up study was conducted at cancer treatment hospitals in Addis Ababa, focusing on children diagnosed with acute lymphocytic leukemia. The investigation covered records from January 1, 2017, to December 30, 2023, encompassing a sample of 230 study records. Variables with a -value below 0.25 in the bivariate analysis were selected for entry into the multivariable analysis. Subsequently, variables demonstrating a -value less than 0.05 in the multivariable Cox proportional hazards model were deemed statistically significant.
The cumulative proportion of survival was 98.3% (95%CI: 94.8, 99.5), 89.2% (95%CI: 82.0, 93.6), and 24.1% (95%CI: 8.43, 44.1) at the end of the 20, 40, and 60 month, respectively. The incidence rate of mortality among cohort of children admitted with acute lymphocytic leukemia was 0.45 per 100 child months. History of relapse (AHR: 2.48; 95%CI: 1.01, 6.08) and infection (AHR: 2.34; 95%CI: 1.03, 5.31) were independent predictors of mortality among children admitted with acute lymphocytic leukemia.
The likelihood of mortality increased in the later stages of follow-up for children admitted with acute lymphocytic leukemia, and the incidence density rate of mortality in this group was lower compared to previous reports from other regions. Furthermore, independent predictors of mortality among children with acute lymphocytic leukemia included a history of relapse and infection.
急性淋巴细胞白血病是一种影响血液和骨髓的癌症,是儿童中最常见的癌症诊断。在埃塞俄比亚,它是儿童白血病的主要形式,约占 80%的病例,是儿童癌症相关死亡的主要原因。因此,本研究旨在探讨在埃塞俄比亚亚的斯亚贝巴癌症治疗医院接受急性淋巴细胞白血病治疗的儿童的生存状况和可能预测死亡率的因素。
在亚的斯亚贝巴癌症治疗医院进行了一项回顾性随访研究,研究对象为诊断为急性淋巴细胞白血病的儿童。研究范围包括 2017 年 1 月 1 日至 2023 年 12 月 30 日的记录,样本包括 230 份研究记录。在双变量分析中 p 值低于 0.25 的变量被选入多变量分析。随后,在多变量 Cox 比例风险模型中 p 值小于 0.05 的变量被认为具有统计学意义。
生存的累积比例分别为 98.3%(95%CI:94.8,99.5)、89.2%(95%CI:82.0,93.6)和 24.1%(95%CI:8.43,44.1)在第 20、40 和 60 个月结束时。急性淋巴细胞白血病患儿入院的死亡率为 0.45/100 儿童月。复发史(AHR:2.48;95%CI:1.01,6.08)和感染(AHR:2.34;95%CI:1.03,5.31)是急性淋巴细胞白血病患儿死亡的独立预测因素。
急性淋巴细胞白血病患儿在随访后期死亡的可能性增加,而该组的死亡率密度低于其他地区的先前报告。此外,急性淋巴细胞白血病患儿死亡的独立预测因素包括复发史和感染史。